PHARMACEUTICAL COMPOUNDING: AN ALTERNATIVE TREATMENT OPTION IN PSORIASIS
- In: What’s new in industry and science? Part 1 on Monday, 23 September 2019, 15:30-15:40
- At: AbuDhabi (United Arab Emirates) (2019)
- Type: Presentation
- By: SONG, Guiyun (PCCA, Research and Development, United States)
- Co-author(s): Guiyun Song: PCCA, Houston, United States
Yashoda Pramar: PCCA, Houston, United States
Daniel Banov: PCCA, Houston, United States
August S. Bassani: PCCA, Houston, United States
Psoriasis is a chronic, immune-mediated inflammatory skin disease that causes significant burden to both the patients and the healthcare system. Commercial medicines including corticosteroids and vitamin D analogues are often used in the topical management of psoriasis due to anti-inflammatory and/or antiproliferative properties.
Met.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.